ABL1 and acute lymphoblastic leukemia: These CRLF2 rearrangements predominantly appear in BCR::ABL1-like and Down syndrome-associated ALL and are generally linked with unfavorable outcomes, primarily when accompanied by IKZF1 mutations [20].